Zobrazeno 1 - 10
of 278
pro vyhledávání: '"Gregory T, Everson"'
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 7, Pp 944-953 (2024)
Background and Aims: We quantified hepatic functional impairment using quantitative function tests and linked severity of functional impairment to liver-related complications and outcome in primary sclerosing cholangitis. Methods: Forty-seven patient
Externí odkaz:
https://doaj.org/article/c6563efb23cd4028a1c03a3542950488
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 4, Pp n/a-n/a (2024)
Abstract Current noninvasive liver tests measure fibrosis, inflammation, or steatosis and do not measure function. The HepQuant platform of noninvasive tests uniquely assesses both liver function and physiology through the hepatic uptake of stable is
Externí odkaz:
https://doaj.org/article/f4dfbddf28ec49fdae033310972eb3ff
Publikováno v:
Translational Research. 252:53-63
The HepQuant SHUNT test quantifies hepatic functional impairment from the simultaneous clearance of cholate from the systemic and portal circulations for the purpose of monitoring treatment effects or for predicting risk for clinical outcome. Compart
Autor:
Jacob A. Langness, David Tabano, Amanda Wieland, Sarah Tise, Lindsay Pratt, Lauren Ayres Harrington, Sonia Lin, Vahram Ghuschcyan, Kavita V. Nair, Gregory T. Everson
Publikováno v:
Annals of Hepatology, Vol 16, Iss 3, Pp 366-374 (2017)
Introduction: Interferon-free, multi-direct acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection is highly effective and well tolerated, but costly. To gain perspective on the evolving economics of HCV therapy, we compared the
Externí odkaz:
https://doaj.org/article/4e219ef2036b406cb61f23792a605454
Autor:
Richard Gilroy, Gregory T. Everson, David S. Goldberg, Norah A. Terrault, Roy D. Bloom, Erin Rubin, Elizabeth A. Pomfret, Robert S. Brown, Russ Wiesner, James R. Burton, Julie K. Heimbach
Publikováno v:
Transplantation. 104:476-481
The development of multiple highly effective and safe direct-acting antivirals to treat hepatitis C virus (HCV) has resulted in greater ease and confidence in managing HCV infection in transplant recipients that in turn has impacted the solid organ t
Autor:
Daniel Ganger, Steve M. Helmke, Lisa B. VanWagner, Gregory T. Everson, Alexander Lemmer, Zaira Gasanova
Publikováno v:
Congenit Heart Dis
Background & aims Fontan surgery for single ventricle congenital heart disease leads to Fontan-associated liver disease (FALD). Typical laboratory tests, imaging, and histopathology cannot predict clinical severity in FALD. HepQuant SHUNT is a propri
Autor:
Gregory T. Everson, Christopher L. Bowlus, Keith D. Lindor, Rachel Gomel, Alexander Kuo, Ricky Safer
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:1372-1378
Background & Aims Primary sclerosing cholangitis (PSC) is a fibrostenosing disease of the bile ducts associated with inflammatory bowel disease (IBD), for which the only treatment is liver transplantation. PSC progression has been defined in cohorts
Autor:
Steve M. Helmke, Gregory T. Everson
Publikováno v:
Gastroenterology. 162:S-1262
Publikováno v:
Gastroenterology. 162:S-1178
Autor:
Mohammad Amin, Fallahzadeh, Daniel J, Hansen, James F, Trotter, Gregory T, Everson, Giovanna, Saracino, Robert S, Rahimi, Steve, Helmke, Jodi, Boutte, Sumeet K, Asrani
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 53(8)
Early identification of risk for decompensation in clinically stable cirrhotic patients helps specialists target early interventions and supports effective referrals from primary care providers to specialty centres.To examine whether the HepQuant-SHU